Senate sunshine provisions would shed light on doctor-industry ties
The Senate Finance Committee has included in its health reform proposal so-called sunshine provisions that would promote transparency among drug and medical device makers that pay doctors for consultations and speeches. AdvaMed backed the sunshine initiative, and the Pharmaceutical Research and Manufacturers of America said any laws on payment disclosures should not imply that doctor-industry ties are inappropriate.
New York Times, The | 11/03
This story published in FDLI SmartBrief on 11/04/2009
More from SmartBrief:
PhRMA guidelines on clinical trials to take effect
Thursday, October 1, 2009
Sources: Drugmakers to spend $150M on ads backing health reform
Monday, August 10, 2009
PhRMA to launch TV ads supporting Sen. Baucus' health plan
Monday, September 21, 2009
Get stories like these delivered daily for FREE:
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|